ORMP
Oramed·NASDAQ
--
--(--)
--
--(--)
7.79 / 10
Outperform
Money flow analysis scores 7.79/10, signaling strong fund inflows across all sizes (extra-large to small). Trends are positive, countering some technical pessimism. However, there is no analyst coverage data available (ana_eval = -1). The combination of robust capital inflows and absent analyst sentiment suggests that price action may be driven primarily by institutional flows rather than consensus recommendations.
Fund Flow Rating
Is money flowing into or out of ORMP?
- ORMP holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.79/10 (Outperform).
